McKesson (NYSE:MCK) Issues FY 2027 Earnings Guidance

Key Points

• FY2027 EPS guidance: McKesson set guidance at 43.800–44.600 per share, roughly in line with the consensus of 44.13, while it did not provide specific revenue guidance.
• Latest quarter: McKesson reported EPS of $11.69, beating estimates of $11.56, but revenue fell short at $96.3 billion versus the $101.35 billion consensus; the stock traded up about 1.3% to $753.43 on the news.
• Analyst and shareholder context: 14 analysts rate the stock a Buy and three Hold with a consensus target of $972.27, and the company announced a quarterly dividend of $0.82 (annualized $3.28, ~0.4% yield).

McKesson (NYSE:MCK - Get Free Report) updated its FY 2027 earnings guidance on Thursday. The company provided EPS guidance of 43.800-44.600 for the period, compared to the consensus EPS estimate of 44.130. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on MCK. UBS Group reduced their price target on shares of McKesson from $1,012.00 to $1,000.00 and set a "buy" rating for the company in a research report on Wednesday, April 22nd. Evercore reissued an "outperform" rating on shares of McKesson in a research report on Thursday, March 5th. Mizuho raised their price target on shares of McKesson from $880.00 to $885.00 and gave the company a "neutral" rating in a research report on Thursday, February 5th. Leerink Partners reissued an "outperform" rating and set a $1,085.00 price target on shares of McKesson in a research report on Thursday, March 5th. Finally, TD Cowen raised their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a "buy" rating in a research report on Thursday, February 5th. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $972.27.

McKesson Trading Up 1.3%

NYSE:MCK traded up $9.76 during trading hours on Thursday, reaching $753.43. The company had a trading volume of 1,941,689 shares, compared to its average volume of 802,130. McKesson has a 52 week low of $637.00 and a 52 week high of $999.00. The firm has a market cap of $92.29 billion, a price-to-earnings ratio of 21.67, a PEG ratio of 1.16 and a beta of 0.35. The firm's 50 day moving average price is $887.83 and its 200-day moving average price is $860.18.

McKesson (NYSE:MCK - Get Free Report) last posted its earnings results on Thursday, May 7th. The company reported $11.69 EPS for the quarter, topping analysts' consensus estimates of $11.56 by $0.13. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $96.30 billion during the quarter, compared to the consensus estimate of $101.35 billion. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. On average, analysts forecast that McKesson will post 39.02 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be given a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, June 1st. McKesson's payout ratio is 9.43%.

Insider Activity at McKesson

In other news, Director Maria Martinez sold 349 shares of the business's stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the sale, the director owned 301 shares of the company's stock, valued at $282,900.87. The trade was a 53.69% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business's stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 3,592 shares of company stock worth $3,518,555. Company insiders own 0.08% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. University of Texas Texas AM Investment Management Co. purchased a new stake in McKesson in the 4th quarter worth $25,000. Swiss RE Ltd. bought a new stake in shares of McKesson in the 4th quarter worth about $26,000. State of Wyoming bought a new stake in shares of McKesson in the 2nd quarter worth about $29,000. Birchwood Financial Partners Inc. bought a new stake in shares of McKesson in the 4th quarter worth about $33,000. Finally, Kemnay Advisory Services Inc. bought a new stake in shares of McKesson in the 4th quarter worth about $39,000. Hedge funds and other institutional investors own 85.07% of the company's stock.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.